Ibrutinib drug page Clinical trials

Trials with Ibrutinib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
4Countries
303Planned patients

Showing 1–2 of 2

Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
Finished Phase 1 40 patients NCT03332498

The purpose of this study is to determine the safety and tolerability, describe the dose-limiting toxicities (DLTs), and determine the maximum tolerated dose (MTD) (or the highest protocol-defined dose level in the absence of establishing …

United States Jan 2018 – Sept 2021 Interventional
Combined with: Pembrolizumab
Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
Finished Phase 1 263 patients NCT02599324

The purpose of this study is to evaluate the safety, tolerability, and efficacy of single agent ibrutinib or the combination treatments of ibrutinib with everolimus, paclitaxel, docetaxel, pembrolizumab or cetuximab in selected advance gas…

United States, South Korea, Spain, United Kingdom Dec 2015 – Aug 2021 Interventional